48- ugers effektdata fra undersøgelse AI266073, hvor Atripla blev administreret til virologisk supprimerede patienter i antiretroviral kombinationsbehandling.
48-week efficacy data from study AI266073 in which Atripla was administered to virologically suppressed patients on combination antiretroviral therapy